You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vedolizumab

Showing 1 - 25 of 195
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

Not yet recruiting
  • Crohn's Disease
  • Vedolizumab
  • +2 more
  • Chicago, Illinois
    University of Chicago Medicine
Sep 13, 2023

Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)

Not yet recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • Vedolizumab IV
  • Vedolizumab SC
  • (no location specified)
Oct 17, 2023

Crohn Disease Trial (Upadacitinib, Vedolizumab)

Not yet recruiting
  • Crohn Disease
  • (no location specified)
Oct 18, 2023

Ulcerative Colitis Trial in Los Angeles (Vedolizumab, Tofacitinib)

Not yet recruiting
  • Ulcerative Colitis
  • Los Angeles, California
    Cedars Sinai Medical Center
Oct 18, 2023

Crohn's Disease Trial (Vedolizumab IV, Placebo)

Not yet recruiting
  • Crohn's Disease
  • Vedolizumab IV
  • Placebo
  • (no location specified)
Apr 20, 2023

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

Immune-Mediated Colitis Trial in Herlev (Vedolizumab, Prednisolone)

Recruiting
  • Immune-Mediated Colitis
  • Herlev, Denmark
    Herlev University Hospital
Aug 16, 2022

VeDOlizumab PERsistence in IBD Patients After Switching From

Recruiting
  • Inflammatory Bowel Diseases
  • Subcutaneous vedolizumab
  • Grenoble, Auvergne-Rhone-Alpes, France
    Thomas Chateau
Aug 2, 2022

Inflammatory Bowel Disease Receiving Vedolizumab in Patient

Not yet recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • No Intervention
  • (no location specified)
Nov 28, 2022

Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV)

Not yet recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • Vedolizumab IV
  • (no location specified)
Jul 21, 2022

Real World Data on Vedolizumab Concentration and Outcomes in

Enrolling by invitation
  • Inflammatory Bowel Diseases
  • +2 more
    • Osijek, Croatia
      Klinički bolnički centar Osijek (University Hospital Center Osij
    Aug 15, 2022

    Type 1 Diabetes Trial in La Jolla, Seattle (Etanercept, Vedolizumab)

    Recruiting
    • Type 1 Diabetes
    • La Jolla, California
    • +1 more
    Jul 21, 2022

    Ulcerative Colitis Trial in Zhengzhou (Vedolizumab)

    Recruiting
    • Ulcerative Colitis
    • Vedolizumab
    • Zhengzhou, Hangzhou, China
      Second Affiliated Hospital Zhejiang University School of Medicin
    Jul 28, 2022

    Healthy Volunteers Trial in Tempe (Vedolizumab SC)

    Completed
    Has Results
    • Healthy Volunteers
    • Vedolizumab SC
    • Tempe, Arizona
      Celerion
    Jul 1, 2022

    Crohn's Disease (CD) Trial in Worldwide (Vedolizumab IV)

    Not yet recruiting
    • Crohn's Disease (CD)
    • Vedolizumab IV
    • (no location specified)
    Mar 21, 2022

    Ulcerative Colitis Trial in Hamilton (Fecal microbiota transplantation)

    Recruiting
    • Ulcerative Colitis
    • Fecal microbiota transplantation
    • Hamilton, Ontario, Canada
      Hamilton Health Sciences
    Aug 23, 2022

    Vedolizumab and Biologic Agents in Inflammatory Bowel Disease

    Completed
    • Inflammatory Bowel Disease (IBD)
    • +2 more
      • Taichung, Taiwan
      • +3 more
      Jan 18, 2023

      Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +5 more
      • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
      • (no location specified)
      Aug 23, 2022

      Vedolizumab SC Given to Moderate to Severe Ulcerative Colitis or

      Not yet recruiting
      • Ulcerative Colitis
      • +2 more
        • (no location specified)
        Jun 24, 2022

        Colitis, Ulcerative Trial in Worldwide (Vedolizumab)

        Recruiting
        • Colitis, Ulcerative
        • Vedolizumab
        • Minneapolis, Minnesota
          MNGI Digestive Health, PA
        Jan 21, 2022

        Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

        Recruiting
        • Ulcerative Colitis
        • Vedolizumab
        • Tokyo, Japan
          Takeda Selected Site
        Apr 26, 2022

        Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

        Not yet recruiting
        • Crohn Disease
        • TNFa Antagonist - Infliximab
        • +5 more
        • Calgary, Alberta, Canada
          University of Calgary
        Jun 22, 2023

        Ulcerative Colitis, Crohn Disease Trial in Surat (Vedolizumab IV)

        Active, not recruiting
        • Ulcerative Colitis
        • Crohn Disease
        • Vedolizumab IV
        • Guntur, Andhra Pradesh, India
        • +17 more
        Jan 26, 2023

        Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

        Recruiting
        • Crohn's Disease
        • Vedolizumab (Genetical Recombination)
        • Tokyo, Japan
          Takeda Selected Site
        Feb 25, 2022

        Ulcerative Colitis, Crohn's Disease Trial in Japan (Vedolizumab)

        Recruiting
        • Ulcerative Colitis
        • Crohn's Disease
        • Vedolizumab
        • Toyota, Aichi, Japan
        • +19 more
        Jun 9, 2022